Source:http://linkedlifedata.com/resource/pubmed/id/17107885
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2006-11-19
|
pubmed:abstractText |
The mechanisms underlying insufficient insulin secretion and loss of beta-cell mass in feline and human type 2 diabetes mellitus are incompletely understood. However, islet amyloid polypeptide (IAPP)-derived islet amyloidosis (IA) has been linked to increased rates of beta-cell apoptosis and, therefore, our goal was to develop an in vitro model of IAPP fibrillogenesis using isolated pancreatic islets from mice transgenic for human IAPP (hIAPP Tg mice). Islets from hIAPP Tg mice, from mice transgenic for non-amyloidogenic murine IAPP (mIAPP Tg mice), and from the FVB background strain were exposed to normal (5.5 mM) or high (28 mM) glucose conditions in cell culture for 8 days. On days 0 and 8, islets were collected for electron microscopy (EM). EM showed no abnormalities in the mIAPP Tg or FVB islets at either time point. On day 8, hIAPP Tg islets cultured at high glucose concentration formed extracellular IAPP-derived flocculent deposits. No significant differences in rates of apoptosis were found between groups. Our findings, therefore, show that in vitro culture of hIAPP Tg mouse islets under high glucose conditions produces a readily available and rapidly inducible model of IAPP-derived fibrillogenesis and enables the study of early phases of the molecular pathogenesis of IA.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Islet Amyloid Polypeptide,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Precursors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1350-6129
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
250-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17107885-Amyloid,
pubmed-meshheading:17107885-Amyloidosis,
pubmed-meshheading:17107885-Animals,
pubmed-meshheading:17107885-Apoptosis,
pubmed-meshheading:17107885-Cells, Cultured,
pubmed-meshheading:17107885-Female,
pubmed-meshheading:17107885-Glucose,
pubmed-meshheading:17107885-Humans,
pubmed-meshheading:17107885-Insulin,
pubmed-meshheading:17107885-Islet Amyloid Polypeptide,
pubmed-meshheading:17107885-Islets of Langerhans,
pubmed-meshheading:17107885-Mice,
pubmed-meshheading:17107885-Mice, Transgenic,
pubmed-meshheading:17107885-Microscopy, Electron, Transmission,
pubmed-meshheading:17107885-Protein Precursors
|
pubmed:year |
2006
|
pubmed:articleTitle |
An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets.
|
pubmed:affiliation |
Veterinary Clinical Sciences Department, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|